Access to health care and the opportunity to achieve optimal health should not depend on where people live, their socioeconomic status, or their race and ethnicity, but as the COVID-19 pandemic has shown, that is not always the case. COVID-related disparities served to shine a light on other areas of…more.
- RWHC Home
- About RWHC
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Behavioral Health
- Movement Disorders
- Big Data
- Multiple Myeloma
- CAR-T Cell Therapy
- Non-Small Cell Lung Cancer
- Nonalcoholic Steatohepatitis
- COVID 19
- Pain Management
- Cystic Fibrosis
- Parkinson’s Disease
- Health Disparities
- Personalized Medicine
- Hepatitis C
- Secondary Progressive MS
- Macular Degeneration
Throughout 2022, Real World Health Care is covering the issue of racial and ethnic health disparities. This week, we explore the topic through the lens of gout, a type of arthritis that has a higher prevalence among racial and ethnic minorities, especially Blacks, than whites. Michael Spigler, vice president of…more.
Studies have shown that cancer disproportionately impacts racial and ethnic minority groups, however, these groups remain underrepresented in cancer clinical trials.1,2,3 With unique insights into issues facing underrepresented patient populations, the Association of Community Cancer Centers (ACCC) recently developed consensus-driven recommendations to improve diversity, equity and accessibility in cancer research.…more.
Social determinants of health (SDOH) have long-term, far-reaching, and not always obvious ramifications in people’s lives, including their risk for Alzheimer’s disease and related dementias (ADRD). These disparities were made clear by a 2020 report issued by UsAgainstAlzheimer’s and the Urban Institute. The report found that deep social inequities –…more.
More than 9.2 million Americans live with gout, but only 10 percent of people with gout are getting the ongoing treatment they need. The lack of proper treatment is particularly acute among Black patients, who have a 25 percent higher prevalence of the disease but are much less likely to…more.
Precision medicine – treatments that are based on an individual’s specific genetics and the cancer cell’s genes – holds great promise for lung cancer patients. For all patients, precision medicine is made possible through a type of advanced diagnostic testing called biomarker testing. However, for some racial and ethnic minorities,…more.
A study published by the Commonwealth Fund in late 2021 found that health systems across the United States are failing people of color. According to the study, Achieving Racial and Ethnic Equity in U.S. Health Care: A Scorecard of State Performance, Black Americans in nearly every state are more likely…more.
This year, Real World Health Care will publish a series of articles about health equity issues facing the Black, Indigenous and People of Color (BIPOC) communities. As a further resource, we invite our readers to listen to the new seasons of the “American Diagnosis” podcast series created and produced by…more.
As I sat down to write my year-end column for 2021, I was struck by how much had changed over the course of the year…and how much remains the same. Thanks to the efforts of brilliant scientists, dedicated clinicians and determined citizens, we now have readily available vaccines (and boosters)…more.
Physicians and Patients Both Have a Role to Play in Eradicating Health Disparities Among African-Americans
Editor’s Note: September is Prostate Cancer Awareness Month and Real World Health Care would like to thank ZERO – The End of Prostate Cancer for reminding us that prostate cancer disproportionately affects Black patients, as detailed in the following article from their Journey to ZERO blog. We invite our subscribers…more.